Oxygenta Pharmaceutical Ltd — Updates, 30-05-2025: Company Update

Oxygenta Pharmaceutical Limited submitted its Secretarial Compliance Report for the financial year ended March 31, 2025, confirming adherence to all applicable SEBI regulations and secretarial standards without any deviations or penalties. The company addressed a prior observation regarding timely disclosure of the appointment of its Company Secretary and Compliance Officer by reaffirming commitment to compliance with disclosure timelines. No violations, director disqualifications, or actions by regulatory bodies were reported. Policies were adopted and updated appropriately, and related party transactions received required approvals, reflecting strong governance and regulatory adherence.